CRON
Price
$2.50
Change
-$0.00 (-0.00%)
Updated
Sep 5 closing price
Capitalization
964.53M
59 days until earnings call
IMCC
Price
$1.97
Change
-$0.08 (-3.90%)
Updated
Sep 5 closing price
Capitalization
10.34M
Interact to see
Advertisement

CRON vs IMCC

Header iconCRON vs IMCC Comparison
Open Charts CRON vs IMCCBanner chart's image
Cronos Group
Price$2.50
Change-$0.00 (-0.00%)
Volume$1.97M
Capitalization964.53M
IM Cannabis
Price$1.97
Change-$0.08 (-3.90%)
Volume$755.84K
Capitalization10.34M
CRON vs IMCC Comparison Chart in %
Loading...
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRON vs. IMCC commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRON is a Hold and IMCC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (CRON: $2.50 vs. IMCC: $1.97)
Brand notoriety: CRON and IMCC are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CRON: 73% vs. IMCC: 1081%
Market capitalization -- CRON: $964.53M vs. IMCC: $10.34M
CRON [@Pharmaceuticals: Generic] is valued at $964.53M. IMCC’s [@Pharmaceuticals: Generic] market capitalization is $10.34M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRON’s FA Score shows that 1 FA rating(s) are green whileIMCC’s FA Score has 0 green FA rating(s).

  • CRON’s FA Score: 1 green, 4 red.
  • IMCC’s FA Score: 0 green, 5 red.
According to our system of comparison, CRON is a better buy in the long-term than IMCC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRON’s TA Score shows that 3 TA indicator(s) are bullish while IMCC’s TA Score has 3 bullish TA indicator(s).

  • CRON’s TA Score: 3 bullish, 6 bearish.
  • IMCC’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, IMCC is a better buy in the short-term than CRON.

Price Growth

CRON (@Pharmaceuticals: Generic) experienced а -3.85% price change this week, while IMCC (@Pharmaceuticals: Generic) price change was -15.09% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.08%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +86.48%.

Reported Earning Dates

CRON is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRON($965M) has a higher market cap than IMCC($10.3M). CRON YTD gains are higher at: 23.762 vs. IMCC (-15.491). IMCC has higher annual earnings (EBITDA): 3.96M vs. CRON (-25.58M). CRON has more cash in the bank: 834M vs. IMCC (794K). CRON has less debt than IMCC: CRON (2.01M) vs IMCC (15.6M). CRON has higher revenues than IMCC: CRON (130M) vs IMCC (52.4M).
CRONIMCCCRON / IMCC
Capitalization965M10.3M9,369%
EBITDA-25.58M3.96M-647%
Gain YTD23.762-15.491-153%
P/E Ratio50.00N/A-
Revenue130M52.4M248%
Total Cash834M794K105,038%
Total Debt2.01M15.6M13%
FUNDAMENTALS RATINGS
CRON: Fundamental Ratings
CRON
OUTLOOK RATING
1..100
26
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
6
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRONIMCC
RSI
ODDS (%)
Bearish Trend 3 days ago
86%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
78%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
85%
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 11 days ago
71%
Bullish Trend 11 days ago
83%
Declines
ODDS (%)
Bearish Trend 13 days ago
84%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
88%
Aroon
ODDS (%)
Bullish Trend 5 days ago
83%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ZEMAX13.630.18
+1.34%
American Beacon Ninety One Emr Mkts Eq Y
CSCIX14.340.12
+0.84%
Cohen & Steers Real Estate Securities C
DIEZX13.150.10
+0.77%
Destinations International Equity Z
AMTAX10.180.01
+0.10%
AB All Market Real Return A
CMCIX27.070.02
+0.07%
Calvert Small/Mid-Cap I

CRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRON has been loosely correlated with TLRY. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if CRON jumps, then TLRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRON
1D Price
Change %
CRON100%
N/A
TLRY - CRON
61%
Loosely correlated
+3.48%
OGI - CRON
58%
Loosely correlated
+2.48%
CGC - CRON
57%
Loosely correlated
+5.80%
ACB - CRON
55%
Loosely correlated
+1.66%
EBS - CRON
29%
Poorly correlated
-0.66%
More

IMCC and

Correlation & Price change

A.I.dvisor tells us that IMCC and SCYX have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IMCC and SCYX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMCC
1D Price
Change %
IMCC100%
-3.90%
SCYX - IMCC
24%
Poorly correlated
+2.43%
TLRY - IMCC
23%
Poorly correlated
+3.48%
CGC - IMCC
22%
Poorly correlated
+5.80%
CRON - IMCC
22%
Poorly correlated
N/A
OGI - IMCC
22%
Poorly correlated
+2.48%
More